logo

Recursion Pharmaceuticals Inc (RXRX) Stock: A Year of Highs and Lows

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -48.22% away from its 52-week high, while its distance from the 52-week low is 76.22%. The stock’s price range over this period has fluctuated between $4.92 and $16.75. The company, operating within the financial sector, had a trading volume of approximately 1.42 million for the day, which was noticeably lower than the average daily share volume of 6.42 million over the last 3 months.

Recursion Pharmaceuticals Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $16.75 on 07/19/23, while the lowest price for the same duration was marked at $4.92 on 05/16/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -8.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.06B.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.23, with a change in price of +1.22. Similarly, Recursion Pharmaceuticals Inc recorded 6,147,356 in trading volume during the last 100 days, posting a change of +16.40%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.

RXRX Stock Stochastic Average

Today’s raw stochastic average for Recursion Pharmaceuticals Inc over the last 50 days is 17.72%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 67.33%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 74.10% and 74.02%, respectively.

RXRX Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded a decrease of -12.07%. However, over the last six months, the performance has been weaker by 46.70%. The price of RXRX decreased -3.67% over the last 30 days. And in the last five days, it has surged by 10.87%.

Most Popular